Ascendis Pharma A/S
Ascendis Pharma A/S（ASND）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
asnd · 股价预测 · 25 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 25 位华尔街分析师
Buy
25 位分析师
共识
评级分布
12 个月目标价
High
$345
Consensus
$288
+36.6% upside
Low
$250
Median: $267.5 · Last Close: $210.45
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$287.50
36.6% upside
High Target
$345
63.9%
Low Target
$250
18.8%
Current Price
$210.45
as of today
Based on analyst price targets, the ASND stock price prediction for the next 12 months ranges from $250 to $345. The consensus ASND price forecast of $287.50 implies 36.6% upside from the current price of $210.45.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $200.13 | ↓ 4.91% |
1-day model range: $199.19–$201.06. Peak: $201.06 (-4.91%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $257 | +22.3% |
| 2028 | $295 | +40.0% |
| 2029 | $323 | +53.2% |
| 2030 | $342 | +62.6% |
| 2031 | — | +69.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ASND · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-11 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-04-16 | B of A Securities | Maintains | Buy→Buy |
| 2026-04-09 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-03 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-02-12 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-12 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-30 | B of A Securities | Maintains | Buy→Buy |
| 2026-01-20 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Ascendis Pharma A/S (ASND) stock. Of the recent 214 rating actions, 6 were upgrades and 6 were downgrades. 25 analysts currently cover ASND.
分析师推荐趋势
ASND analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.3B
↓ 45.1% YoY
Revenue Next Year
$1.9B
↑ 44.4% YoY
EPS This Year
$13.52
EPS Next Year
$9.47
↓ 30.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ASND EPS of $13.52 for the current fiscal year, based on estimates from 10 analysts. The ASND revenue forecast is $1.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ASND 股价预测由两类独立数据源支撑：来自 25 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ASND 的共识目标价为 $287.50（+36.6% 上行空间），分析师共识为 Buy。
ASND 的短期预测（明日）为 $200.13（-4.91%）。 ASND 对 2027 年的股价预测均值为 $257。 ASND 对 2030 年的预测区间为 $325–$360。
Ascendis Pharma A/S 在 NASDAQ 上市，代码 ASND。ASND 在 2027 年的整体展望偏积极，在覆盖分析师中约 92% 对应 Buy 共识。
常见问题
ASND 预测 · 8 个问题根据 25 位华尔街分析师，ASND 的 12 个月平均目标价为 $287.50，最高 $345.00、最低 $250.00。若有图表，中位目标价可在上方查看。相对当前价 $210.45，隐含约 +36.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.